Description
A higher-dose research format of Retatrutide, this triple agonist peptide is studied for its enhanced efficacy in obesity, insulin resistance, and type 2 diabetes models. It supports advanced investigations into energy metabolism, glycemic control, and body fat reduction.
CURRENT BATCH: black lid
NET PEPTIDE CONTENT: 22.33Mg
Reviews
There are no reviews yet.